Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
39.89
+0.88 (2.26%)
Apr 28, 2026, 3:00 PM CST
34.04% (1Y)
| Market Cap | 27.05B |
| Revenue (ttm) | 4.92B |
| Net Income (ttm) | 2.13B |
| Shares Out | 770.09M |
| EPS (ttm) | 2.77 |
| PE Ratio | 14.40 |
| Forward PE | 27.32 |
| Dividend | 4.68 (12.00%) |
| Ex-Dividend Date | Feb 12, 2026 |
| Volume | 3,361,550 |
| Average Volume | 3,446,324 |
| Open | 39.00 |
| Previous Close | 39.01 |
| Day's Range | 38.92 - 39.89 |
| 52-Week Range | 29.19 - 50.97 |
| Beta | 0.74 |
| RSI | 41.39 |
| Earnings Date | Mar 31, 2026 |